Plain-English translation of NCT06350617 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing repetitive transcranial magnetic stimulation (rTMS)—a non-invasive brain stimulation technique—to help people with Parkinson's disease improve their walking and movement. Rather than using the same treatment for everyone, this study creates a personalized plan based on whether your strengths are more in physical movement or thinking and memory. The goal is to see if this customized approach works better than the standard one-size-fits-all brain stimulation currently used.
Traditional brain stimulation for Parkinson's uses the same protocol for all patients, but people with Parkinson's have different abilities and different areas of strength. This trial exists because researchers think a personalized approach—targeting the brain areas that match each person's individual pattern of strengths—might lead to better improvements in walking and daily function.
You likely qualify if…
You likely don't qualify if…
First, you'll complete screening tests that measure your walking ability and thinking skills to see which group you belong to. Then you'll be randomly assigned to receive one of several personalized brain stimulation protocols—either stimulation over one or both sides of your motor brain area, or over a thinking-related brain area, depending on your strengths. You'll come in for treatment sessions over several weeks, during which magnetic coils are placed against your scalp to deliver painless brain stimulation. Throughout the study, your walking and movement abilities will be measured to see if the treatment helps.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
South Korea